肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2011年
4期
237-239
,共3页
金文波%周乃康%郑梦利%祁彦君%马连君
金文波%週迺康%鄭夢利%祁彥君%馬連君
금문파%주내강%정몽리%기언군%마련군
食管肿瘤%黏蛋白类%角蛋白质类%肿瘤转移
食管腫瘤%黏蛋白類%角蛋白質類%腫瘤轉移
식관종류%점단백류%각단백질류%종류전이
Esophageal neoplasms%Mucins%Keratins%Neoplasm metastasis
目的 研究食管癌患者外周血黏蛋白-1(MUC1)和细胞角蛋白-20(CK20)表达情况及临床意义.方法 采用反转录聚合酶链反应(RT.PCR)方法检测53例食管癌患者外周血MUC1-mRNA和CK20-mRNA水平,以10例食管良性肿瘤患者及20名健康体检者为对照.结果 在良性肿瘤组及健康对照组中,MUC1-mRNA及CK20-mRNA均无表达,而在食管癌患者中的阳性率分别是35.85%(19/53)和49.06%(26/53),二者联合检测阳性率为62.26%(36/53),较单项阳性率高(x2=11.0228,P<0.05).二者在食管癌患者中的表达与患者性别、年龄及肿瘤分化程度无明显相关性,而与肿瘤临床分期明显相关.结论 MUC1-mRNA和CK20-mRNA作为食管癌肿瘤标志物具有较高的敏感性及特异性;其表达与食管癌的临床分期密切相关;两种标志物联合检测有助于提高食管癌微转移的检出率.
目的 研究食管癌患者外週血黏蛋白-1(MUC1)和細胞角蛋白-20(CK20)錶達情況及臨床意義.方法 採用反轉錄聚閤酶鏈反應(RT.PCR)方法檢測53例食管癌患者外週血MUC1-mRNA和CK20-mRNA水平,以10例食管良性腫瘤患者及20名健康體檢者為對照.結果 在良性腫瘤組及健康對照組中,MUC1-mRNA及CK20-mRNA均無錶達,而在食管癌患者中的暘性率分彆是35.85%(19/53)和49.06%(26/53),二者聯閤檢測暘性率為62.26%(36/53),較單項暘性率高(x2=11.0228,P<0.05).二者在食管癌患者中的錶達與患者性彆、年齡及腫瘤分化程度無明顯相關性,而與腫瘤臨床分期明顯相關.結論 MUC1-mRNA和CK20-mRNA作為食管癌腫瘤標誌物具有較高的敏感性及特異性;其錶達與食管癌的臨床分期密切相關;兩種標誌物聯閤檢測有助于提高食管癌微轉移的檢齣率.
목적 연구식관암환자외주혈점단백-1(MUC1)화세포각단백-20(CK20)표체정황급림상의의.방법 채용반전록취합매련반응(RT.PCR)방법검측53례식관암환자외주혈MUC1-mRNA화CK20-mRNA수평,이10례식관량성종류환자급20명건강체검자위대조.결과 재량성종류조급건강대조조중,MUC1-mRNA급CK20-mRNA균무표체,이재식관암환자중적양성솔분별시35.85%(19/53)화49.06%(26/53),이자연합검측양성솔위62.26%(36/53),교단항양성솔고(x2=11.0228,P<0.05).이자재식관암환자중적표체여환자성별、년령급종류분화정도무명현상관성,이여종류림상분기명현상관.결론 MUC1-mRNA화CK20-mRNA작위식관암종류표지물구유교고적민감성급특이성;기표체여식관암적림상분기밀절상관;량충표지물연합검측유조우제고식관암미전이적검출솔.
Objective To investigate the expressions and clinical significances of MUC1-mRNA and CK20-mRNA in peripheral blood of esophageal cancer patients.Methods MUC1-mRNA and CK20-mRNA were detected in 53 patients with esophageal cancer,10 patients with esophageal benign tumor and 20 healthy volunteers by RT-PCR technique.Results The expressions of MUC1-mRNA,CK20-mRNA and combining group were 35.85 % (19/53),49.06 % (26/53) and 62.26 % (36/53) in peripheral blood of 53 esophageal cancer patients.In control group,there was no expression of MUC1-mRNA and CK20-mRNA in peripheral blood of 10 patients with benign esophageal disease and 20 healthy volunteers.The positive rate increased by combining test(x2 =11.0228,P <0.05).Conclusion MUC1-mRNA and CK20-mRNA might be specific and sensitive markers to detect circulating tumor cells in peripheral blood and their expressions are closely related to TNM stages of the esophageal cancer patients.The combining test might be of high value of the diagnosis of micrometastasis.